Plain-English translation of NCT07554820 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Rheumatoid Arthritis research guide →Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This trial is testing whether a medication called tofacitinib, when given together with a cholesterol-lowering drug, can safely treat severe rheumatoid arthritis while protecting the heart. The study will compare this new combination approach to the standard treatment that doctors currently use. Researchers want to understand whether this medication is as safe as existing treatments for people with rheumatoid arthritis who are at risk for heart problems.
Rheumatoid arthritis patients often face a higher risk of heart disease, and doctors need to find treatments that control the arthritis without putting the heart at greater risk. This study is checking whether this new combination approach can manage severe arthritis effectively while keeping the heart safe.
You likely qualify if…
You likely don't qualify if…
You would visit the clinic once a month for 6 months while taking either the new medication combination or the standard treatment. At each visit, doctors will check your arthritis activity, measure your cholesterol and other heart health markers, and ask about any side effects or heart-related symptoms. If you experience any serious heart events, the study team will stop the new medication and provide you with appropriate care.
AI-generated summary from trial data · Jun 11, 2026 · Not medical advice
Pakistan